NEWS & EVENTS

GemPharmatech announces research collaboration with leading cancer center to advance antibody discovery

GemPharmatech, a global leader in preclinical research solutions and genetically-engineered mouse models, today announced a collaboration with Memorial Sloan Kettering Cancer Center (MSK) to accelerate the discovery of new therapeutic antibodies.

Distribution agreement provides Japanese researchers streamlined access to GemPharmatech’s mouse models and preclinical services.

GemPharmatech partners with FUJIFILM Wako Pure Chemical, and Institute of Immunology Co., Ltd., to expand access to preclinical mouse models and services in Japan

GemPharmatech Strengthens Collaboration with Japan’s Research Community

On September 16, GemPharmatech was honored to host a scientific seminar at Shonan Health Innovation Park (Shonan iPark), one of Japan’s leading hubs for life sciences and drug discovery. As the country’s first pharma-led, open innovation ecosystem, Shonan iPark provides a vital platform for researchers and companies to collaborate and accelerate biomedical innovation.

GemPharmatech and Setsuro Tech Announce Distributor Agreement to Support Japanese Biomedical Research Community

GemPharmatech, a global leader in genetically engineered mouse models and preclinical research services, is proud to announce the establishment of a distributor agreement with Setsuro Tech Inc., a leading gene editing service provider based in Tokushima. This agreement marks a significant step by GemPharmatech towards serving the needs of Japan’s biomedical research community more closely and effectively.

GemPharmatech Significantly Expands U.S. Capabilities with New San Diego Biotech Hub Facility

GemPharmatech, a global leader in genetically engineered mouse models and preclinical contract research services, today announced the grand opening of its newly expanded U.S. headquarters in San Diego's premier biotech corridor, marking a significant milestone in the company's North American expansion strategy.

GemPharmatech Joins Shonan Health Innovation Park, Expanding and Strengthening Research Support in Japan

GemPharmatech, a global leader in genetically engineered mouse models and preclinical research services, today announced its official entry into Shonan Health Innovation Park (Shonan iPark). This strategic move marks a significant milestone in the company's expansion into the Japanese market and reinforces it commitment to advancing biomedical research and innovation worldwide.

GemPharmatech and Goodwill Announce Strategic Partnership to Advance AI-Driven PDX Model Ecosystem for Cancer Drug Development

GemPharmatech Co., Ltd., a global leader in mouse model development and preclinical research services, has entered into a comprehensive strategic partnership with Goodwill E-Health Info Co., Ltd., a pioneer in clinical data governance and medical AI. The collaboration aims to create a cutting-edge, AI-enhanced Patient-Derived Xenograft (PDX) model database to accelerate cancer treatment innovation and translational medicine.

GemPharmatech Named One of China’s Top 100 Life Science Service Brands for 2024

GemPharmatech has been named one of the “Top 100 Brands of Chinese Life Science Service Enterprises” for 2024 by Healthcare Executive, a leading voice in China’s pharmaceutical industry. The recognition highlights GemPharmatech’s growing influence as a trusted research partner in China’s rapidly advancing biotech landscape.

GemPharmatech Leads Global Collaboration Dialogue at BIOCHINA Forum in San Diego